Results for untargeted MS search on m/z: (+/-) mode
Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
---|---|---|---|---|---|---|---|---|---|---|
AN001833 | 61.99 | 0.75 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 116.93 | 5.14 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 119.04 | 4.95 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 119.04 | 5.61 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 119.04 | 6.46 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 127 | 10.82 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 127 | 11.57 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 139.01 | 5.13 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 172.96 | 11.87 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 172.96 | 11.98 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 184.04 | 11.22 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 230.05 | 10.8 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 244.06 | 10.82 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 244.06 | 11.57 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 248.97 | 4.35 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 248.97 | 4.95 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 248.97 | 5.1 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 248.97 | 5.2 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 248.97 | 5.62 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 248.97 | 6.1 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 248.97 | 6.25 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 248.97 | 6.45 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 248.97 | 6.64 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 248.97 | 6.8 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 248.97 | 6.96 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 248.97 | 7.3 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 248.97 | 7.51 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 248.97 | 7.67 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 248.97 | 7.95 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 248.97 | 9.42 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 248.97 | 9.78 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 248.97 | 11.45 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 253.22 | 1.88 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 267.23 | 2.29 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 279.23 | 2.12 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 279.23 | 2.25 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 281.25 | 2.78 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 281.25 | 6.04 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 281.25 | 6.37 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 283.26 | 11.23 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 283.26 | 11.79 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 293.18 | 0.83 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 295.26 | 3.15 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 301.22 | 1.52 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 303.23 | 1.97 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 305.25 | 2.42 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 305.25 | 2.57 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 307.26 | 2.98 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 308.03 | 0.75 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 309.28 | 3.41 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 319.23 | 0.83 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 321.28 | 3.28 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 327.23 | 1.75 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 329.25 | 2.2 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 331.26 | 2.75 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 333.28 | 3.22 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 335.3 | 3.55 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 337.31 | 3.99 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 339.33 | 4.64 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 357.28 | 2.97 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 359.29 | 3.34 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 363.25 | 2.78 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 363.33 | 4.11 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 365.25 | 2.73 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 365.34 | 4.66 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 369.24 | 5.13 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 377.25 | 2.78 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 377.27 | 7.86 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 377.27 | 8.94 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 377.27 | 9.27 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 377.27 | 9.54 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 377.27 | 9.83 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 377.27 | 9.97 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 377.27 | 10.56 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 377.27 | 10.8 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 377.27 | 11.16 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 377.27 | 11.3 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 379.23 | 2.79 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 391.29 | 5.11 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 391.29 | 7.88 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 391.29 | 9.56 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 391.29 | 9.83 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 391.29 | 9.96 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 391.29 | 10.55 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 391.29 | 10.8 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 391.29 | 10.96 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 391.29 | 11.25 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 391.29 | 11.58 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 391.29 | 11.87 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 392.29 | 11.24 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 393.37 | 5.41 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 395.06 | 0.64 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 395.39 | 6.23 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 406.31 | 3.4 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 412.08 | 0.75 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 415.31 | 2.89 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 421.23 | 0.83 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 422.3 | 2.8 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 429.08 | 0.61 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 431.04 | 0.64 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 433.04 | 0.64 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 433.33 | 11.23 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 436.28 | 1.87 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 445.06 | 1.08 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 447.05 | 0.75 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 452.28 | 1.62 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 455.09 | 0.75 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 458.06 | 0.64 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 462.3 | 2.03 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 463.33 | 4.69 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 463.33 | 9.55 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 463.33 | 11.23 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 463.33 | 11.85 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 464.31 | 2.81 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 465.3 | 2.97 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 465.33 | 5.14 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 469.1 | 0.75 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 472.07 | 0.75 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 477.36 | 3.43 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 478.29 | 1.78 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 480.31 | 2.48 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 491.36 | 4.27 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 491.36 | 4.95 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 491.36 | 5.63 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 492.35 | 3.44 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 500.28 | 1.21 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 505.37 | 4.69 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 505.37 | 4.95 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 505.37 | 5.62 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 505.37 | 7.88 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 505.37 | 8.94 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 505.37 | 9.17 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 505.37 | 9.28 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 505.37 | 9.55 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 505.37 | 10.8 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 505.37 | 11.23 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 505.37 | 11.88 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 506.29 | 1.9 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 506.33 | 2.63 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 506.38 | 5.59 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 509.06 | 0.64 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 523.07 | 0.75 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 528.27 | 1.38 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 542.43 | 4.68 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 544.45 | 5.23 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 546.45 | 5.23 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 554.35 | 1.59 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 554.48 | 5.25 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 555.05 | 0.64 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 558.46 | 5.59 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 560.46 | 5.59 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 569.06 | 0.75 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 570.46 | 5.34 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 572.46 | 5.33 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 574.48 | 5.96 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 574.5 | 6.2 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 574.61 | 7.01 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 576.48 | 5.96 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 577.34 | 3.2 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 580.36 | 1.62 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 580.36 | 1.76 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 580.49 | 5.35 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 582.38 | 2.43 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 582.51 | 5.96 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 582.54 | 6.61 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 583.38 | 3.81 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 588.48 | 5.62 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 596.53 | 5.96 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 596.53 | 6.3 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 597.53 | 6.3 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 598.5 | 6.05 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 599.32 | 1.54 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 599.52 | 5.93 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 600.5 | 6.05 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 603.51 | 6.68 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 610.54 | 6.67 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 611.54 | 6.66 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 613.5 | 7.8 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 613.52 | 2.79 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 614.53 | 7.04 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 614.56 | 7.98 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 618.58 | 7.44 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 624.56 | 6.67 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 627.49 | 6.71 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 627.5 | 6.64 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 627.52 | 7.22 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 629.49 | 7.26 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 629.54 | 7.37 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 631.49 | 7.25 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 631.51 | 7.89 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 636.56 | 6.78 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 636.59 | 7.4 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 638.57 | 7.38 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 640.58 | 8.1 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 641.55 | 3.4 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 642.56 | 7.74 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 642.59 | 8.62 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 646.48 | 5.59 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 650.57 | 6.78 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 651.47 | 6.56 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 652.59 | 7.38 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 653.5 | 6.77 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 654.56 | 7.48 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 657.52 | 7.92 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 659.51 | 5.11 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 660.58 | 8.07 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 662.48 | 5.26 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 662.55 | 6.49 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 664.59 | 7.45 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 664.62 | 8.07 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 666.6 | 8.06 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 666.64 | 8.66 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 668.61 | 8.75 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 670.48 | 5.11 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 670.59 | 8.39 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 670.63 | 9.26 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 671.59 | 8.39 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 671.63 | 9.25 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 672.5 | 5.68 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 672.5 | 5.79 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 672.57 | 7.74 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 674.51 | 6.29 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 674.57 | 7.71 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 675.49 | 6.35 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 677.49 | 6.58 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 677.55 | 6.8 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 678.56 | 6.89 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 679.03 | 2.17 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 679.51 | 7.27 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 679.56 | 7.33 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 679.6 | 7.44 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 680.62 | 8.06 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 680.62 | 8.38 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 681.51 | 7.28 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 682.59 | 8.14 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 682.6 | 7.89 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 682.6 | 8.3 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 683.57 | 7.46 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 683.59 | 8.08 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 684.59 | 8.24 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 685.59 | 8.01 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 685.66 | 5.74 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 686.48 | 5.13 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 686.51 | 5.99 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 686.59 | 8.02 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 687.48 | 9.52 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 687.54 | 5.05 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 688.49 | 5.32 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 688.49 | 5.45 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 689.53 | 7.26 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 690.51 | 5.93 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 690.58 | 7.2 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 690.6 | 7.44 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 690.64 | 8.06 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 692.62 | 7.7 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 692.62 | 7.83 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 692.62 | 8.03 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 692.65 | 8.72 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 693.47 | 4.25 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 694.59 | 7.78 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 694.63 | 8.7 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 695.64 | 8.7 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 696.49 | 5.98 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 696.5 | 5.54 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 696.61 | 8.35 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 697.61 | 8.38 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 698.51 | 5.83 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 698.61 | 8.36 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 698.62 | 9 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 699.48 | 9.17 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 699.98 | 9.17 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 700.49 | 5.12 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 700.49 | 9.55 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 700.53 | 6.36 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 700.6 | 7.21 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 700.6 | 7.67 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 700.6 | 8.38 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 700.99 | 9.54 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 701.49 | 9.88 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 701.53 | 6.6 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 702 | 9.88 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 702.51 | 5.68 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 702.53 | 5.13 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 702.55 | 6.99 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 702.61 | 8.36 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 702.77 | 6.36 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 704.56 | 7.08 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 704.62 | 7.44 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 706.5 | 4.65 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 706.58 | 7.38 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 706.63 | 8.03 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 707.58 | 7.92 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 707.59 | 7.46 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 708.5 | 5.31 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 708.65 | 8.7 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 709.61 | 8 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 709.61 | 8.15 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 710.51 | 5.86 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 710.64 | 8.67 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 711.48 | 8.91 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 711.58 | 8.57 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 711.63 | 8.69 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 711.98 | 8.91 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 712.49 | 5.11 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 712.49 | 9.23 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 712.63 | 8.67 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 712.64 | 9.29 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 713.49 | 9.55 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 713.63 | 8.66 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 714 | 9.54 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 714.5 | 9.9 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 714.51 | 5.5 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 714.51 | 5.82 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 714.54 | 6.6 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 715 | 9.9 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 715.51 | 5.5 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 715.51 | 10.25 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 716.01 | 10.25 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 716.52 | 6 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 718.61 | 7.88 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 719.49 | 3.97 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 719.49 | 4.3 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 720.5 | 5.13 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 720.5 | 5.24 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 721.5 | 4.78 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 722.51 | 5.69 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 722.51 | 5.81 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 724.49 | 8.98 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 724.52 | 6.68 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 724.53 | 5.84 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 724.53 | 5.93 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 724.53 | 6.2 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 724.99 | 8.98 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 725.5 | 9.29 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 725.99 | 9.29 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 726.5 | 9.6 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 726.54 | 6.42 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 726.54 | 6.51 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 727 | 9.61 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 727.51 | 9.9 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 728.01 | 9.9 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 728.52 | 5.82 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 728.56 | 7.04 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 730.54 | 6.37 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 730.57 | 7.06 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 730.58 | 7.66 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 731.58 | 7.14 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 732.48 | 4.4 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 732.5 | 5.14 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 732.52 | 4.72 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 733.5 | 4.57 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 733.55 | 4.4 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 734.59 | 8.08 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 734.67 | 8.65 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 735.52 | 5.11 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 736.51 | 4.5 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 736.53 | 5.91 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 736.53 | 6 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 736.55 | 5.55 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 737.53 | 5.9 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 737.54 | 5.05 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 738.51 | 5.11 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 738.51 | 5.37 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 738.54 | 6.37 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 738.54 | 6.55 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 740.51 | 5.12 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 740.52 | 5.57 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 740.52 | 5.69 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 740.52 | 5.84 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 740.64 | 7.19 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 742.54 | 6.08 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 744.5 | 5.11 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 744.55 | 5.88 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 744.56 | 5.29 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 744.56 | 6.71 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 745.5 | 4.07 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 745.5 | 4.39 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 746.51 | 5.28 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 746.51 | 5.5 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 747.52 | 4.43 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 747.52 | 4.83 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 747.52 | 5.13 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 748.53 | 5.75 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 748.53 | 5.92 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 750.53 | 6.79 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 750.54 | 5.84 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 750.54 | 6.19 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 750.54 | 6.38 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 751.55 | 6.79 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 752.53 | 5.75 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 752.55 | 7.38 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 752.56 | 6.7 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 752.56 | 6.88 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 754.54 | 5.85 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 754.57 | 6.84 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 754.57 | 7.14 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 755.58 | 6.82 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 756.55 | 6.4 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 756.59 | 7.69 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 757.59 | 7.69 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 758.57 | 7.03 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 758.58 | 5.3 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 758.6 | 7.48 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 759.56 | 4.51 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 760.51 | 4.85 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 760.52 | 5.12 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 760.53 | 5.83 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 760.61 | 8.05 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 761.54 | 5.13 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 762.51 | 5.19 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 762.53 | 4.63 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 762.56 | 6.02 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 762.58 | 5.02 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 762.62 | 8.7 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 763.57 | 5.03 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 763.58 | 5.31 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 764.52 | 5.44 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 764.52 | 5.6 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 764.54 | 4.92 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 764.54 | 5.14 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 764.56 | 6.54 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 766.54 | 5.88 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 766.54 | 6.06 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 766.56 | 7.73 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 768.54 | 5.85 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 768.55 | 6.25 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 768.55 | 6.36 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 768.55 | 6.56 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 769.54 | 5.82 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 770.51 | 5.12 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 770.53 | 5.8 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 770.57 | 6.73 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 771.52 | 4.17 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 771.52 | 4.5 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 771.57 | 6.7 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 772.53 | 5.55 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 772.57 | 5.12 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 772.58 | 7.37 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 773.53 | 4.52 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 773.53 | 4.89 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 773.54 | 5.11 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 774.53 | 5.16 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 774.54 | 5.8 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 774.54 | 6.17 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 774.55 | 5.94 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 774.56 | 5.11 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 774.56 | 5.6 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 775.55 | 4.98 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 775.55 | 5.11 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 775.55 | 5.43 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 776.53 | 5.15 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 776.56 | 6.21 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 776.56 | 6.4 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 776.56 | 6.61 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 776.57 | 6.1 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 776.58 | 5.73 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 777.56 | 6.22 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 777.57 | 6.12 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 778.55 | 5.79 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 778.57 | 7.49 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 778.58 | 6.74 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 778.58 | 6.86 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 778.58 | 7.07 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 778.59 | 6 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 778.59 | 6.23 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 780.56 | 6.26 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 780.58 | 8.08 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 780.59 | 7.37 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 782.53 | 6.36 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 782.61 | 7.76 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 784.62 | 8.31 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 786.52 | 7.04 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 786.53 | 5.02 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 786.54 | 5.84 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 786.63 | 8.01 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 788.52 | 5.26 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 788.54 | 4.71 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 788.54 | 5.45 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 788.54 | 5.81 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 788.58 | 6.18 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 788.64 | 8.69 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 789.56 | 5.8 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 790.54 | 5.86 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 790.56 | 5.18 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 790.56 | 5.25 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 790.57 | 5.77 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 790.59 | 6.3 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 790.59 | 6.72 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 792.55 | 6.09 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 792.56 | 5.87 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 792.56 | 6.32 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 792.57 | 5.58 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 792.57 | 5.81 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 792.58 | 7.7 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 793.5 | 3.92 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 793.56 | 5.9 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 794.55 | 5.87 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 794.57 | 6.37 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 794.57 | 6.55 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 794.57 | 6.74 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 794.6 | 8.39 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 795.52 | 4.13 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 795.59 | 10.18 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 795.6 | 8.38 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 796.53 | 5.15 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 796.55 | 5.87 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 796.58 | 7.04 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 797.53 | 4.35 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 797.53 | 4.51 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 797.55 | 5.86 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 798.53 | 6.01 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 798.6 | 7.38 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 798.64 | 7.2 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 799.55 | 4.61 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 799.55 | 5.12 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 800.46 | 6.37 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 800.54 | 5.14 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 800.56 | 5.95 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 800.56 | 6.19 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 800.62 | 8.03 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 801.56 | 5.12 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 801.56 | 5.47 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 801.57 | 5.03 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 802.52 | 6.71 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 802.56 | 5.35 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 802.56 | 5.53 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 802.56 | 5.84 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 802.57 | 5.78 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 802.57 | 6.6 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 802.57 | 6.86 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 802.59 | 6.2 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 803.58 | 5.54 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 804.56 | 5.65 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 804.57 | 5.55 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 804.58 | 7.47 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 804.6 | 7.06 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 804.61 | 6.3 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 805.54 | 5.68 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 806.5 | 4.28 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 806.53 | 5.13 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 806.59 | 6.16 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 806.59 | 6.49 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 806.6 | 7.41 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 806.6 | 8 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 806.62 | 8.7 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 808.55 | 6.43 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 808.58 | 6.48 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 808.61 | 8.71 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 809.52 | 4.63 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 810.53 | 4.9 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 812.54 | 4.62 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 812.54 | 5.15 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 814.55 | 5.13 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 814.56 | 4.91 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 814.56 | 5.49 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 814.56 | 5.8 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 814.58 | 7.2 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 815.56 | 5.5 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 816.56 | 5.87 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 816.57 | 6.15 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 816.58 | 5.37 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 816.61 | 6.82 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 817.5 | 3.69 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 817.58 | 5.36 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 817.64 | 6.48 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 818.58 | 6.55 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 818.59 | 5.88 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 819.52 | 3.98 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 819.64 | 9.28 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 819.64 | 9.57 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 819.64 | 10.21 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 820.59 | 6.75 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 820.6 | 6.27 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 820.6 | 6.53 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 820.61 | 8.34 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 821.53 | 4.27 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 821.55 | 5.02 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 821.63 | 7.18 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 822.59 | 5.89 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 822.59 | 6.55 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 822.6 | 7.08 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 822.62 | 7.4 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 822.63 | 9 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 823.55 | 4.61 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 823.59 | 6.56 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 824.54 | 6.1 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 824.58 | 5.53 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 824.58 | 6.57 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 824.66 | 7.18 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 825.56 | 4.8 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 825.56 | 5.06 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 826.56 | 5.26 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 826.56 | 6.73 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 826.59 | 5.65 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 826.63 | 7.99 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 827.56 | 6.71 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 827.58 | 5.12 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 828.55 | 5.49 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 828.57 | 5.43 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 828.61 | 6.26 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 828.65 | 8.64 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 828.66 | 7.4 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 829.52 | 4.83 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 829.6 | 5.59 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 829.66 | 7.4 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 830.59 | 5.61 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 830.59 | 5.95 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 830.63 | 6.37 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 830.63 | 6.89 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 830.63 | 7.04 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 831.66 | 7.18 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 832.55 | 6.37 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 832.6 | 6.22 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 832.61 | 6.57 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 832.61 | 8.12 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 832.64 | 7.03 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 832.64 | 7.73 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 833.52 | 4.3 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 833.64 | 7.01 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 833.64 | 7.73 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 834.53 | 4.74 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 834.62 | 7.18 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 834.63 | 8.62 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 835.53 | 4.72 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 836.54 | 4.92 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 836.63 | 7.08 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 836.64 | 9.31 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 837.55 | 4.99 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 838.55 | 5.13 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 838.56 | 4.68 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 838.56 | 4.84 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 838.56 | 5.32 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 840.57 | 4.94 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 840.57 | 5.26 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 840.58 | 5.85 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 840.6 | 7.17 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 841.5 | 3.64 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 842.58 | 5.77 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 842.59 | 5.42 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 842.59 | 5.55 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 842.59 | 6.15 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 842.62 | 7.9 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 842.63 | 6.79 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 842.67 | 7.4 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 843.58 | 5.05 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 844.58 | 5.04 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 844.6 | 6.55 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 844.61 | 5.94 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 845.53 | 4.07 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 846.55 | 5.12 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 846.62 | 6.57 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 847.44 | 4.81 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 847.55 | 4.41 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 847.57 | 5.11 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 847.65 | 7.4 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 847.66 | 7.16 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 847.66 | 7.18 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 848.45 | 4.81 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 848.54 | 6.08 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 848.63 | 7.38 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 848.64 | 7.56 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 848.65 | 7.17 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 849.56 | 4.76 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 849.59 | 5.62 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 849.64 | 7.16 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 849.66 | 7.86 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 850.56 | 5.12 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 850.58 | 6.58 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 850.65 | 8.06 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 850.66 | 7.85 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 851.58 | 4.91 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 851.58 | 5.13 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 852.61 | 5.7 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 853.59 | 5.34 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 854.63 | 6.53 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 854.66 | 7.37 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 855.61 | 5.71 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 856.69 | 8.05 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 857.52 | 4.23 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 857.67 | 6.8 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 857.67 | 7.14 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 857.69 | 8.05 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 858.54 | 5.3 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 858.62 | 6.27 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 858.62 | 6.61 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 858.66 | 7.68 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 859.53 | 4.37 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 859.53 | 4.61 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 859.69 | 7.53 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 859.69 | 7.86 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 860.6 | 6.86 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 860.61 | 5.07 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 860.64 | 7.15 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 860.67 | 8.36 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 861.55 | 4.75 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 861.55 | 5.04 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 862.65 | 7.05 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 862.68 | 8.32 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 863.57 | 5.29 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 864.57 | 4.85 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 864.57 | 5.1 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 865.5 | 3.56 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 865.58 | 5.61 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 866.59 | 5.3 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 867.52 | 3.67 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 867.54 | 4.35 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 868.61 | 5.74 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 868.61 | 5.93 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 868.69 | 7.37 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 869.53 | 3.92 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 869.67 | 6.56 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 870.62 | 6.06 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 870.68 | 6.54 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 870.7 | 8.05 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 871.53 | 4.5 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 871.69 | 7.15 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 872.56 | 5.27 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 872.64 | 6.6 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 873.55 | 4.89 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 873.58 | 5.31 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 874.57 | 5.12 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 874.58 | 5.79 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 874.65 | 7.24 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 874.69 | 8.64 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 875.56 | 5.12 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 875.57 | 5.31 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 875.59 | 5.75 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 876.57 | 6.54 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 876.6 | 4.9 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 876.65 | 7.25 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 880.6 | 7.38 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 881.52 | 4.11 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 883.53 | 4.28 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 883.53 | 4.41 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 884.54 | 4.27 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 885.55 | 4.76 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 885.55 | 5.13 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 886.7 | 7.87 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 887.57 | 5.02 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 887.57 | 5.15 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 887.82 | 5.15 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 889.58 | 5.42 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 890.58 | 5.14 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 890.58 | 5.41 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 891.6 | 5.85 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 892.6 | 5.35 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 892.61 | 5.74 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 894.62 | 5.76 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 894.62 | 5.95 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 896.48 | 5.67 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 896.59 | 5.1 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 896.64 | 6.43 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 897.55 | 4.53 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 898.58 | 5.35 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 898.65 | 6.72 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 899.57 | 5.1 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 899.67 | 9.32 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 900.51 | 6.44 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 900.57 | 5.11 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 900.59 | 5.87 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 900.67 | 7.25 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 901.58 | 5.31 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 901.58 | 5.47 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 902.61 | 6.49 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 903.6 | 5.7 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 907.53 | 4.16 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 909.55 | 4.32 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 909.55 | 4.62 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 911.56 | 4.78 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 911.56 | 5.01 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 913.58 | 5.15 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 915.59 | 5.14 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 915.6 | 5.62 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 915.6 | 5.81 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 916.59 | 5.13 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 917.61 | 6.01 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 918.52 | 6.72 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 924.67 | 7.4 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 926.61 | 5.97 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 927.68 | 7.18 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 928.62 | 6.58 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 929.63 | 6.56 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 937.77 | 10.61 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 942.63 | 7.4 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 944.7 | 7.12 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 952.65 | 6.44 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 952.71 | 8.05 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 953.69 | 7.15 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 954.64 | 6.61 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 955.71 | 7.86 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 955.97 | 9.41 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 955.97 | 9.77 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 955.97 | 10.16 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 965.53 | 4.28 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 966 | 6.45 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 966 | 6.96 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 966 | 9.5 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 966 | 9.82 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 966 | 9.99 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 966 | 10.25 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 966.63 | 6.8 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 967.55 | 4.75 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 968.65 | 7.37 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 969.57 | 5.15 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 970.66 | 8.07 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 970.72 | 7.09 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 973.74 | 7.77 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 981.02 | 9.88 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 981.02 | 12.29 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 985.47 | 4.76 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 987.49 | 5.16 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 988.73 | 7.61 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 996.67 | 6.95 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 1006.7 | 7.08 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 1009.72 | 7.74 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 1022.66 | 4.91 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 1024.7 | 7.61 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 1025.96 | 12.43 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 1032.75 | 7.76 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 1058.64 | 4.91 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 1079.98 | 11.93 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 1106.75 | 6.95 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 1142.73 | 6.94 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 1151.7 | 4.02 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 1192.79 | 6.91 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 1194.81 | 7.6 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells | |
AN001833 | 1196.81 | 7.59 | Minutes | ST001120 | NEGATIVE | Agilent 6550 QTOF | Reversed phase | Human | Cultured cells |